The Law Offices of Frank R. Cruz Announces Investigation of Applied Therapeutics, Inc. (APLT) on Behalf of Investors
- 76
The Law Offices of Frank R. Cruz announces an investigation of Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ: APLT) on behalf of investors concerning the Company’s possible violations of federal securities laws.
If you are a shareholder who suffered a loss, click here to participate.
On November 27, 2024, Applied Therapeutics disclosed that it had received a Complete Response Letter (“CRL”) from the U.S. Food and Drug Administration (“FDA”) regarding the New Drug Application (“NDA”) for the Company’s Classic Galactosemia drug, govorestat, stating that "[t]he CRL indicates that the FDA completed its review of the application and determined that it is unable to approve the NDA in its current form, citing deficiencies in the clinical application."
On this news, Applied Therapeutics’ stock price fell $6.54, or 76.3%, to close at $2.03 per share on November 29, 2024, thereby injuring investors.
Follow us for updates on Twitter: twitter.com/FRC_LAW.
If you purchased Applied Therapeutics securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 2121 Avenue of the Stars, Suite 800, Century City, California 90067 at 310-914-5007, by email to [email protected], or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241211165242/en/
- DNP Achieves Fine Pattern Resolution on EUV Lithography Photomasks for Beyond 2nm Generation
- HAS Investors Have Opportunity to Lead Hasbro, Inc. Securities Fraud Lawsuit
- EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
- CMG Investors Have Opportunity to Lead Chipotle Mexican Grill, Inc. Securities Fraud Lawsuit
- TD DEADLINE: ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages The Toronto-Dominion Bank Investors with Losses in Excess of $100k to Secure Counsel Before Important December 23 Deadline in Securities Class Action - TD
- LadRx Planning NDA Submission under 505(b)(2) for Aldoxorubicin and Other Updates
